November 15, 2022 Comments Off on New patent for Global Blood drug OXBRYTA Posted in: Patent Added Annual Drug Patent Expirations for OXBRYTA Oxbryta is a drug marketed by Global Blood Theraps and is included in two NDAs. There are nine patents protecting this drug. This drug…
The post New patent for Global Blood drug OXBRYTA appeared first on DrugP…
November 15, 2022 Comments Off on New patent for Teva Pharm drug ARMONAIR DIGIHALER Posted in: Patent Added Annual Drug Patent Expirations for ARMONAIR+DIGIHALER Armonair Digihaler is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are twenty-four…
The post New patent for Teva Pharm drug ARMONAIR DIGIHALER a…